> Detailanzeige

Moledina, Zahra; McPhee, Margaret; Ravenscroft, Jane C; Healy, Eugene; Radley, Kathy; Thomas, Kim S; Burden-Teh, Esther; Burden-Teh, Esther; Healy, Eugene; Hepburn, Trish; Layfield, Carron; Layton, Alison; Leighton, Paul; Leng, Simon; Mitchell, Miss Eleanor; Northover, Guy; Radley, Kathy; Ramesh, Miss Grishma; Ravenscroft, Jane C; Sach, Tracey; Santer, Miriam; Thomas, Kim S; Thompson, Andrew; Whitehouse, Heather;

How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals
  • Beteiligte: Moledina, Zahra; McPhee, Margaret; Ravenscroft, Jane C; Healy, Eugene; Radley, Kathy; Thomas, Kim S; Burden-Teh, Esther; Burden-Teh, Esther; Healy, Eugene; Hepburn, Trish; Layfield, Carron; Layton, Alison; Leighton, Paul; Leng, Simon; Mitchell, Miss Eleanor; Northover, Guy; Radley, Kathy; Ramesh, Miss Grishma; Ravenscroft, Jane C; Sach, Tracey; Santer, Miriam; Thomas, Kim S; Thompson, Andrew; Whitehouse, Heather;
  • Erschienen: Oxford University Press (OUP), 2023
  • Erschienen in: Clinical and Experimental Dermatology, 48 (2023) 1, Seite 20-23
  • Sprache: Englisch
  • DOI: 10.1093/ced/llac015
  • ISSN: 0307-6938; 1365-2230
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Abstract We undertook a survey of UK healthcare professionals through the UK Dermatology Clinical Trials Network and British Dermatological Nursing Group to understand clinicians’ routine practice of prescribing oral isotretinoin for treatment of acne vulgaris. We also wanted to understand clinicians’ experiences and views on prescribing low daily dose regimens. Overall, the survey showed that clinicians adopted a patient-centred approach when deciding isotretinoin dosing. The rationale for using a low-dose regimen varied, but was focused on patient wellbeing during treatment. Some clinicians were concerned that use of a low-dose regimen could be less effective and lead to longer treatment durations. The survey results will be useful to inform a clinical trial investigating the effectiveness and safety of low daily dose isotretinoin for the treatment of acne.